Skip to Content

Generic Drug Approvals: July 2006

First Time Generic Approvals

  • Metoprolol Succinate Extended-Release Tablets USP 25 mg
    Approved: July 31, 2006 Sandoz Inc.
    Generic for: Toprol-XL Extended Release Tablets
  • Finasteride Tablets USP 1 mg
    Approved: July 28, 2006 Dr. Reddy’s Laboratories Limited
    Generic for: Propecia Tablets
  • Estradiol Transdermal System 0.0375 mg/24 hours and 0.06 mg/24 hours (Additional Strengths)
    Approved: July 20, 2006 Mylan Technologies, Inc.
    Generic for: Climara Transdermal System
  • Meloxicam Tablets 7.5 mg and 15 mg
    Approved: July 19, 2006 Breckenridge Pharmaceutical, Inc., Corepharma LLC, Caraco Pharmaceutical Laboratories, Ltd., Lupin Limited, Mylan Pharmaceuticals, Inc., Watson Laboratories, Inc., Zydus Pharmaceuticals USA, Inc., Roxane Laboratories, Inc., Teva Pharmaceuticals, USA, Glenmark Pharmaceuticals Ltd., Par Pharmaceutical, Mutual Pharmaceutical Company, Inc., Actavis Totowa LLC, Lupin Limited
    Generic for: Mobic Tablets
  • Azithromycin for Oral Suspension USP, 100 mg/5 mL and 200 mg/5 mL
    Approved: July 5, 2006 Pliva, Inc.
    Generic for: Zithromax for Oral Suspension

Other Generic Approvals

Generic Approvals Archive